Coexistence of β2 microglobulin and λ light chain in amyloid fibrils of dialysis-unrelated plasma cell dyscrasia-associated systemic amyloidosis

British Journal of Dermatology

Volumn 147, Issue 3, 2002, Pages 549-553

  Fujimoto, Norihiro ^a   Wada, N ^a   Akiyama, M ^a   Tajima, S ^a   Ishibashi, A ^a   Miyakawa, S ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Amyloid fibril; Immunoglobulin light chain; Systemic amyloidosis; 2 microglobulin

Indexed keywords

AMYLOID; ANTIBODY; BETA 2 MICROGLOBULIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN;

ADULT; AGED; AMYLOIDOSIS; ANTIGEN ANTIBODY REACTION; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; MOLECULAR WEIGHT; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; SKIN DEFECT; CHEMISTRY; METABOLISM; MIDDLE AGED; MULTIPLE MYELOMA; PARAPROTEINEMIA; SKIN;

AGED; AMYLOIDOSIS; BETA 2-MICROGLOBULIN; HUMANS; IMMUNOGLOBULIN LAMBDA-CHAINS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PARAPROTEINEMIAS; SKIN;

EID: 0035982905     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04940.x     Document Type: Article

References (25)

1. Myeloma paraproteinemias, and the skin
2. Multiple myeloma and other plasma cell disorders
3. Amyloid fibril proteins: Proof of homology with immunoglobulin light chains by sequence analyses
4. Structural identity of Bence Jones and amyloid fibril proteins in a patient with plasma cell dyscrasia and amyloidosis
5. Monoclonal immunoglobulin deposition disease: Light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis
6. Aberrant immunoglobulin synthesis in light chain amyloidosis. Free light chain and light chain fragment production by human bone marrow cells in short-term tissue culture
7. Relevance of class, molecular weight and isoelectric point in predicting human light chain amyloidogenicity
8. 2-microglobulin
9. 2-microglobulin
10. 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis
11. 2-microglobulin and amyloidosis
12. 2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis
13. 2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis
14. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure
15. N-(epsilon)-(carboxymethyl) lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction
16. The characterization of soluble amyloid prepared in water
17. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
18. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedures and some applications
19. 2-microglobulin: Its significance in the evaluation of renal function
20. Beta 2-microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients
21. 2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis
22. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1
23. Ultrastructural evidence for colocalization of kappa light chain- and beta 2-microglobulin-derived amyloids using double labelling immunogold electron microscopy
24. Mixed systemic amyloidosis in a patient receiving long term haemodialysis
25. Nodular macroglossia with combined light chain and beta-2 microglobulin deposition in a long-term dialysis patient